Position in INBX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,229,144
+$104,044 QoQ
Shares Held
33,157
+23.3% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Derivatives in INBX
reported options exposure · as of Mar 31, 2026CallValue
$2,312,712
CallShares
34,400
PutValue
$242,028
PutShares
3,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names. INBX ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in INBX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,312,712 | 34,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $242,028 | 3,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $2,229,144 | 33,157 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,125,100 | 26,900 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $3,460,200 | 43,800 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $10,854,600 | 137,400 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $1,926,293 | 57,194 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $496,645 | 35,500 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $5,596 | 400 | Put | Defined | 2025-05-15 | |
| 2024-12-31 | $21,560 | 1,400 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $534,765 | 34,725 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $90,828 | 5,800 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $760,684 | 48,575 | Call | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||